Middle East and North Africa-Rxilient

Home
Markets

The Gulf markets of the UAE, Kuwait, Oman, and Saudi Arabia together serve over 55 million residents through healthcare systems built on subsidised care for citizens, strong hospital investment, and private insurance for large expatriate populations. Each government is transforming on its own timeline: the UAE extending mandatory insurance across all seven emirates, Kuwait expanding capacity and formalising expatriate insurance under Vision 2035, Oman launching its National Health Policy 2025–2035 under Vision 2040, and Saudi Arabia is restructuring care into regional health clusters under its Vision 2030 transformation program.

As the Gulf accelerates toward Vision-driven healthcare reform, Rxilient is positioning itself as a long-term partner across the region's evolving regulatory and insurance landscape—helping bring innovative therapies to patients matching the pace of the Gulf’s healthcare ambitions.

Our Products

Rxolve^® Ultra
Rxolve^® Soothe

Middle East and North Africa Office Contact

Company Name

RXILIENT MEDICAL PTE.LTD. (FZ BRANCH)
Address

Unit No: UPT-YCBC-SO47, Uptown Tower, Plot No: DMCC-UD-T2, Uptown Dubai, Dubai, United Arab Emirates
Email

enquiry_ae@Rxilient.com